Wenfeng Li, Yuanshen Mao, Bao Hua, Xin Gu, Chao Lu, Bin Xu, & Weixin Pan. (2022). Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways. Taylor & Francis Group.
Chicago Style (17th ed.) CitationWenfeng Li, Yuanshen Mao, Bao Hua, Xin Gu, Chao Lu, Bin Xu, and Weixin Pan. Sasanquasaponin Inhibited Epithelial to Mesenchymal Transition in Prostate Cancer by Regulating the PI3K/Akt/mTOR and Smad Pathways. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationWenfeng Li, et al. Sasanquasaponin Inhibited Epithelial to Mesenchymal Transition in Prostate Cancer by Regulating the PI3K/Akt/mTOR and Smad Pathways. Taylor & Francis Group, 2022.
Warning: These citations may not always be 100% accurate.